New IDF Publications for Clinicians
This year, IDF published two important educational publications for clinicians caring for patients with primary immunodeficiency diseases (PI).
Immune Deficiency Foundation Diagnostic & Clinical Care Guidelines for Primary Immunodeficiency Diseases
The Immune Deficiency Foundation Diagnostic & Clinical Care Guidelines for Primary Immunodeficiency Diseases has been one of the Foundation’s most popular publications, and the new third edition is now available. In partnership with expert immunologists, IDF developed these guidelines to enhance earlier diagnosis, improve health outcomes and increase access to specialized healthcare and optimal treatment for patients with PI. The original Guidelines was published in 2006, and minor revisions were made in the second edition in 2009. The third edition has been thoroughly reviewed and updated, and contains information on:
- Selected Primary Immunodeficiency Diseases
- Antibody Production Defects
- Cellular or Combined Defects
- Phagocytic Cell Immune Defects
- Mendelian Susceptibility to Mycobacterial Disease
- Complement Defects
- Genetic Counseling: General Considerations and Practical Aspects
- Health Insurance
It also includes a new section on Mendelian Susceptibility to Mycobacterial Disease and updated International Classification of Diseases (ICD) codes. These guidelines are not only intended to better educate physicians on the recognition, diagnosis and optimal treatment of these diseases, but they are also intended to provide patients with resources to deal more effectively with their physicians and with insurance providers. This publication was sponsored by Baxalta US Inc.
Clinical Focus on Primary Immunodeficiencies: Subcutaneous Immunoglobulin Replacement
IDF also published the new edition of Clinical Focus on Primary Immunodeficiencies: Subcutaneous Immunoglobulin Replacement. As use of subcutaneous immunoglobulin (SCIG) continues to grow in the U.S., more clinicians are using this delivery system for their patients and may not understand all the subtleties and importance of this method and the proper administration. There are also many questions about how to deal with side effects and reactions. Not only does this publication offer appropriate guidelines for SCIG, but it also answers commonly asked questions about SCIG and provides in-depth details about the many options for SCIG administration. This publication was funded by an unrestricted educational grant from CSL Behring.
You can download PDF versions or order copies at www.primaryimmune.org/idf-publications, or if you prefer contact IDF at 800-296-4433 or email@example.com to order hard copies.